291 related articles for article (PubMed ID: 30595291)
1. Role of metabolic manipulator trimetazidine in limiting percutaneous coronary intervention-induced myocardial injury.
Kazmi DH; Kapoor A; Sinha A; Ambesh P; Kashyap S; Khanna R; Kumar S; Garg N; Tewari S; Goel PK
Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S365-S371. PubMed ID: 30595291
[TBL] [Abstract][Full Text] [Related]
2. The effect of trimetazidine treatment in patients with type 2 diabetes undergoing percutaneous coronary intervention for AMI.
Li R; Tang X; Jing Q; Wang Q; Yang M; Han X; Zhao J; Yu X
Am J Emerg Med; 2017 Nov; 35(11):1657-1661. PubMed ID: 28587952
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of an acute oral loading dose of trimetazidine on myocardial injury following percutaneous coronary intervention.
Bonello L; Sbragia P; Amabile N; Com O; Pierre SV; Levy S; Paganelli F
Heart; 2007 Jun; 93(6):703-7. PubMed ID: 17488771
[TBL] [Abstract][Full Text] [Related]
4. Trimetazidine administration minimizes myocardial damage and improves left ventricular function after percutaneous coronary intervention.
Labrou A; Giannoglou G; Zioutas D; Fragakis N; Katsaris G; Louridas G
Am J Cardiovasc Drugs; 2007; 7(2):143-50. PubMed ID: 17503885
[TBL] [Abstract][Full Text] [Related]
5. Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.
Gordin J; Haider A; Swaminathan RV; Kim LK; Minutello RM; Bergman G; Wong SC; Feldman DN
Am J Cardiol; 2012 Nov; 110(10):1397-404. PubMed ID: 22858186
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Trimetazidine in Limiting Periprocedural Myocardial Injury in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
Wang C; Chen W; Yu M; Yang P
Angiology; 2021 Jul; 72(6):511-523. PubMed ID: 33472383
[TBL] [Abstract][Full Text] [Related]
7. Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention.
Nageh T; Sherwood RA; Harris BM; Byrne JA; Thomas MR
Int J Cardiol; 2003 Dec; 92(2-3):285-93. PubMed ID: 14659867
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of Myocardial Biomarkers in the Diagnosis of Myocardial Infarction After Revascularization as Assessed by Cardiac Resonance: The Medicine, Angioplasty, Surgery Study V (MASS-V) Trial.
Hueb W; Gersh BJ; Alves da Costa LM; Costa Oikawa FT; Vieira de Melo RM; Rezende PC; Garzillo CL; Lima EG; Nomura CH; Villa AV; Hueb AC; Cassaro Strunz CM; Favarato D; Takiuti ME; de Albuquerque CP; Ribeiro da Silva EE; Franchini Ramires JA; Kalil Filho R
Ann Thorac Surg; 2016 Jun; 101(6):2202-8. PubMed ID: 26912303
[TBL] [Abstract][Full Text] [Related]
9. Heart type fatty acid binding protein is more sensitive than troponin I and creatine kinase myocardial band at early stage in determining myocardial injury caused by percutaneous coronary intervention.
Ozdemir L; Elonu OH; Gocmen AY
Int Heart J; 2011; 52(3):143-5. PubMed ID: 21646735
[TBL] [Abstract][Full Text] [Related]
10. Protection from procedural myocardial injury by omega-3 polyunsaturated fatty acids (PUFAs): is related with lower levels of creatine kinase-MB (CK-MB) and troponin I?
Foroughinia F; Salamzadeh J; Namazi MH
Cardiovasc Ther; 2013 Oct; 31(5):268-73. PubMed ID: 23134549
[TBL] [Abstract][Full Text] [Related]
11. Trimetazidine on ischemic injury and reperfusion in coronary artery bypass grafting.
Martins GF; Siqueira Filho AG; Santos JB; Assunção CR; Bottino F; Carvalho KG; Valência A
Arq Bras Cardiol; 2011 Sep; 97(3):209-16. PubMed ID: 21808851
[TBL] [Abstract][Full Text] [Related]
12. The effect of intravenous vitamin C infusion on periprocedural myocardial injury for patients undergoing elective percutaneous coronary intervention.
Wang ZJ; Hu WK; Liu YY; Shi DM; Cheng WJ; Guo YH; Yang Q; Zhao YX; Zhou YJ
Can J Cardiol; 2014 Jan; 30(1):96-101. PubMed ID: 24365194
[TBL] [Abstract][Full Text] [Related]
13. Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes.
Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC
Am J Cardiol; 2009 Nov; 104(9):1210-5. PubMed ID: 19840564
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of elevated troponin I after percutaneous coronary intervention.
Cantor WJ; Newby LK; Christenson RH; Tuttle RH; Hasselblad V; Armstrong PW; Moliterno DJ; Califf RM; Topol EJ; Ohman EM;
J Am Coll Cardiol; 2002 Jun; 39(11):1738-44. PubMed ID: 12039485
[TBL] [Abstract][Full Text] [Related]
15. Effects of remote ischemic preconditioning on myocardial injury and endothelial function and prognosis after percutaneous coronary intervention in patients with acute coronary syndrome.
Zhou FZ; Song W; Yin LH; Song ZF; Yang S; Yang FB; Liu JF; Song YG; Zhang HY; Zhang ZM
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4642-4648. PubMed ID: 29131250
[TBL] [Abstract][Full Text] [Related]
16. High-sensitivity cardiac troponin decrease after percutaneous coronary intervention in patients with stable coronary artery disease.
Hamaya R; Horie T; Yonetsu T; Sugano A; Kanaji Y; Usui E; Hoshino M; Yamaguchi M; Ohya H; Sumino Y; Hada M; Hirano H; Kanno Y; Yuki H; Hirao K; Kakuta T
Heart Vessels; 2019 Jun; 34(6):948-956. PubMed ID: 30600349
[TBL] [Abstract][Full Text] [Related]
17. Effect of one-cycle remote ischemic preconditioning to reduce myocardial injury during percutaneous coronary intervention.
Zografos TA; Katritsis GD; Tsiafoutis I; Bourboulis N; Katsivas A; Katritsis DG
Am J Cardiol; 2014 Jun; 113(12):2013-7. PubMed ID: 24793669
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness of preoperative trimetazidine on myocardial preservation in coronary artery bypass graft patients: a systematic review and meta-analysis.
Zhang N; Lei J; Liu Q; Huang W; Xiao H; Lei H
Cardiology; 2015; 131(2):86-96. PubMed ID: 25871315
[TBL] [Abstract][Full Text] [Related]
19. Effects of persistent platelet reactivity despite aspirin therapy on cardiac troponin I and creatine kinase-MB levels after elective percutaneous coronary interventions.
Gulmez O; Yildirir A; Kaynar G; Konas D; Aydinalp A; Ertan C; Ozin B; Muderrisoglu H
J Thromb Thrombolysis; 2008 Jun; 25(3):239-46. PubMed ID: 17574519
[TBL] [Abstract][Full Text] [Related]
20. Lack of efficacy of clopidogrel pre-treatment in the prevention of myocardial damage after elective stent implantation.
van der Heijden DJ; Westendorp IC; Riezebos RK; Kiemeneij F; Slagboom T; van der Wieken LR; Laarman GJ
J Am Coll Cardiol; 2004 Jul; 44(1):20-4. PubMed ID: 15234399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
